Global Sufentanil Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Global Sufentanil Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Pharmaceutical
  • Upcoming Reports
  • Jan 2025
  • Global
  • 350 Páginas
  • Número de tabelas: 220
  • Número de figuras: 60

Global Sufentanil Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Chart Image USD 191.66 Million USD 395.54 Million 2024 2032
Diagram Período de previsão
2025 –2032
Diagram Tamanho do mercado (ano base )
USD 191.66 Million
Diagram Tamanho do mercado ( Ano de previsão)
USD 395.54 Million
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Manequim1
  • Manequim2
  • Manequim3
  • Manequim4
  • Manequim5

>Global Sufentanil Market Segmentation, By Indication (OpioidAnalgesic and Anaesthetic), Route of Administration (Intravenous Route, Epidural Route, and Sublingual Route), Drug Type (Branded and Generic), Doses (Adult, Pediatrics, and Geriatric), End Users (Hospitals, Clinics, and Other), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2032

Sufentanil Market

Sufentanil Market Analysis

The sufentanil market is experiencing growth driven by its extensive use as a potent opioid analgesic and anesthetic in surgical and critical care settings. Known for its high potency and rapid onset, sufentanil is widely preferred in pain management protocols, especially for severe and acute pain. The market is segmented based on drug type (branded and generic), route of administration (intravenous, epidural, sublingual), and end users, including hospitals, clinics, and ambulatory surgical centers. Recent developments highlight advancements in drug delivery systems, enhancing precision and patient safety, alongside increased generic drug approvals to improve affordability. Key players such as Janssen Pharmaceuticals, Mallinckrodt, and Akorn Operating Company LLC are focused on R&D and strategic collaborations to expand their portfolios. With the rising prevalence of chronic pain conditions and an increasing number of surgeries, the sufentanil market is poised for sustained growth, while regulatory scrutiny continues to shape its trajectory.

Sufentanil Market Size

The global sufentanil market size was valued at USD 191.66 million in 2024 and is projected to reach USD 395.54 million by 2032, with a CAGR of 10.17% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Sufentanil Market Trends

Integration of Advanced Drug Delivery Systems”

The sufentanil market is witnessing significant growth, driven by its critical role as a potent opioid analgesic in surgical and acute pain management. Known for its rapid onset and efficacy, sufentanil remains a preferred choice in anesthesia and pain control protocols. Innovations such as sublingual sufentanil tablets and advanced drug delivery systems are enhancing precision, patient compliance, and safety. A key market trend is the rising adoption of generic formulations, which are boosting accessibility and affordability amid increasing healthcare cost concerns. The market's growth is further fueled by the expanding number of surgical procedures and advancements in critical care management, positioning sufentanil as a vital component in modern healthcare solutions.

Report Scope and Sufentanil Market Segmentation  

Attributes

Sufentanil  Key Market Insights

Segments Covered

  • By Indication: Opioid Analgesic and Anaesthetic
  • By Route of Administration: Intravenous Route, Epidural Route, and Sublingual Route
  • By Drug Type: Branded and Generic
  • By Doses: Adult, Pediatrics, and Geriatric
  • By End Users: Hospitals, Clinics, and Other
  • By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Key Market Players

ICP Shanghai (China), Johnson & Johnson Services, Inc. (U.S.), Cambrex Corporation (U.S.), Mallinckrodt (U.K.), hameln rds s.r.o (Germany), Kern Pharma (Spain), Cristália (Brazil), Akorn Operating Company LLC (U.S.), Johnson Matthey (U.K.)

Market Opportunities

  • Development of New Formulations
  • Generic Drug Expansion

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Sufentanil Market Definition

Sufentanil is a synthetic opioid analgesic belonging to the fentanyl family, characterized by its high potency—approximately 5 to 10 times more potent than fentanyl. It is primarily used in medical settings as an anesthetic adjunct during surgeries and for managing severe acute pain in critical care scenarios. Administered through intravenous, epidural, or sublingual routes, sufentanil acts on the central nervous system by binding to opioid receptors, producing powerful pain relief and sedation. Its rapid onset and short duration of action make it a preferred choice in controlled medical environments, although its potency necessitates careful dosing and monitoring to avoid adverse effects such as respiratory depression.

Sufentanil Market Dynamics

Drivers

  • Rising Preference for Opioids in Anesthesia

Sufentanil’s potent analgesic properties make it a preferred choice in anesthesia, especially for high-risk surgeries and patients with specific medical conditions such as those with cardiovascular issues, obesity, or respiratory conditions. Its ability to provide strong, fast-acting pain relief with minimal doses reduces the risk of side effects, making it ideal for patients who require precise, controlled pain management. This has led to its increasing adoption in surgical settings, driving market demand. Furthermore, its effectiveness in managing severe acute pain during and after surgery enhances its role in critical care, positioning sufentanil as a key driver of market growth in the anesthesia and pain management sectors.

  • Increasing Surgical Procedures

The rising number of surgeries worldwide, especially in fields such as orthopedics, cardiology, and neurology, is significantly boosting the demand for effective analgesics such as sufentanil. As surgical procedures become more complex and common, there is an increasing need for potent pain relief during and after operations. Sufentanil, with its high potency and rapid onset, is an ideal choice for managing severe pain in these high-stakes medical environments. Its effectiveness in providing adequate pain control while minimizing side effects is driving its adoption across various surgical disciplines. This growing demand for surgical pain management is a major driver behind the expansion of the sufentanil market.

Opportunities

  • Development of New Formulations

The introduction of innovative sufentanil delivery methods, such as sublingual tablets and extended-release formulations, represents a significant market opportunity. These new delivery systems offer several advantages, including improved patient compliance and ease of use, as they eliminate the need for intravenous or epidural administration. Sublingual tablets, for instance, provide rapid pain relief while reducing the complexity and discomfort associated with injectable forms. Extended-release formulations can help in managing long-term pain, expanding sufentanil's use beyond acute settings to outpatient care and chronic pain management. This innovation broadens the patient base and opens new opportunities for the sufentanil market, particularly in ambulatory and home-care settings.

  • Generic Drug Expansion

The availability of generic versions of sufentanil presents a significant market opportunity by making the drug more affordable and increasing its accessibility to a broader range of healthcare providers. Generic formulations typically cost less than branded alternatives, enabling hospitals, clinics, and other medical facilities to incorporate sufentanil into their pain management protocols without straining budgets. This affordability enhances its adoption, particularly in cost-sensitive markets and healthcare systems with limited resources. The increased availability of generic sufentanil can also drive usage across a wider variety of treatment settings, including outpatient care, emergency departments, and pain management clinics, thereby expanding the overall market for this opioid analgesic.

Restraints/Challenges

  • Competition from Alternative Pain Management Options

The presence of other analgesics, including non-opioid alternatives and opioids with lower abuse potential, poses a significant challenge to the sufentanil market. Non-opioid pain relievers, such as acetaminophen, NSAIDs, and newer non-opioid therapies, are increasingly preferred due to their lower risk of addiction and fewer side effects. In addition, opioids with a lower risk of misuse, such as tramadol or hydrocodone, are being used more frequently in pain management protocols, further limiting the demand for high-potency opioids such as sufentanil. These alternatives are gaining popularity among healthcare providers due to safety concerns associated with opioid use, creating increased competition for sufentanil in the pain management market.

  •  High Cost of Production

The production of sufentanil, especially in novel formulations such as sublingual tablets or extended-release versions, presents a significant market restraint due to the high costs associated with their development and manufacturing. These advanced formulations require specialized production processes, quality control measures, and rigorous clinical testing, all of which contribute to higher production expenses. As a result, the final price of these formulations can be significantly higher compared to traditional injectable forms, limiting their affordability and accessibility, particularly in cost-sensitive healthcare systems. This pricing challenge may restrict widespread adoption, especially in lower-income regions, slowing down market growth and limiting sufentanil's reach.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Sufentanil Market Scope

The market is segmented on the basis of indication, route of administration, drug type, doses, end users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Opioid analgesic
  • Anaesthetic

Route of Administration

  • Intravenous route
  • Epidural route
  • Sublingual route

Drug Type

  • Branded
  • Generic

Doses

  • Adult
  • Pediatrics
  • Geriatric

End Users

  • Hospitals
  • Clinics
  • Others

Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

Sufentanil Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, indication, route of administration, drug type, doses, end users, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominate the largest market share due to widespread availability of sufentanil in healthcare settings, coupled with high levels of physician awareness regarding advanced treatment options. In addition, substantial healthcare spending by both private companies and governments supports the market's growth. This financial investment enhances access to cutting-edge medical treatments, driving the demand for potent analgesics such as sufentanil in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Sufentanil Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Sufentanil Market Leaders Operating in the Market Are:

  • ICP Shanghai (China)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Cambrex Corporation (U.S.)
  • Mallinckrodt (U.K.)
  • hameln rds s.r.o (Germany)
  • Kern Pharma (Spain)
  • Cristália (Brazil)
  • Akorn Operating Company LLC (U.S.)
  • Johnson Matthey (U.K.)

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

O mercado é segmentado com base em Segmentation, By Indication (Opioid Analgesic and Anaesthetic), Route of Administration (Intravenous Route, Epidural Route, and Sublingual Route), Drug Type (Branded and Generic), Doses (Adult, Pediatrics, and Geriatric), End Users (Hospitals, Clinics, and Other), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2032 .
O tamanho do Global Sufentanil Market foi avaliado em USD 191.66 USD Million no ano de 2024.
O Global Sufentanil Market está projetado para crescer a um CAGR de 10.17% durante o período de previsão de 2025 a 2032.
O relatório de mercado cobre dados de U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Testimonial